Samsung Biologics

207940.KO

674.22 USD

-1.91

-0.28%

Overview

Last close

674.22 usd

Market cap

31.21B usd

52 week high

741.11 usd

52 week low

634.23 usd

Target price

673.5 usd

Valuation

P/E

N/A

Forward P/E

36.4964

Price/Sales

15.9586

Price/Book Value

9.76

Enterprise Value

48.60B usd

EV/Revenue

15.8362

EV/EBITDA

25.9452

Key financials

Revenue TTM

3.07B usd

Gross Profit TTM

1.68B usd

EBITDA TTM

1.82B usd

Earnings per Share

N/A usd

Dividend

N/A usd

Total assets

7.67B usd

Net debt

533.63M usd

About

Samsung Biologics Co.,Ltd., together with its subsidiaries engages in the manufacturing, commercializing, distributing, and selling of biopharmaceuticals products in South Korea, Europe, the United States, and internationally. Its development services include late discovery, cell line development, process development, analytical development, and non-GMP / CGMP manufacturing. The company also offers aseptic filling, lyophilization, finishing, cold chain storage and shipping, and regulatory support services; and quality services and analytical testing services, such as IPC and release testing, stability study and testing, environmental monitoring, biosafety testing, as well as manufactures drug substance. In addition, it engages in the development and manufacture of antibody-drug conjugates and mRNA products. The company was founded in 2011 and is headquartered in Incheon, South Korea.